Program-Rome-2018

Rome Program

2nd INTERNATIONAL KELOID SYMPOSIUM
at PONTIFICIA UNIVERSITÀ SAN TOMMASO D’AQUINO

Rome, Italy – June 7-8, 2018

Time

Title

Speaker

DAY 1
Thursday, June 7, 2018

7:30 – 8:30

Registration and Breakfast

8:30 – 8:45

Welcome – Opening Ceremony

8:45 -10:30

Setting the Scene: Basic Understanding of Keloid Disorder

Clinical Presentation of Keloid Disorder; A Retrospective Study of 1088 Patients and Recommendation for Keloid Staging System.

Michael H. Tirgan, MD

Understanding Biology of Keloid Disorder Through Data Analysis

Joel Correa da Rosa, PhD

Age of Onset of Keloid Disorder, Correlation between the Age at Onset and Clinical Manifestation of the Disorder; A Retrospective Multivariate Study of 1329 Patients.

Fernanda Oliveria Balbino, PhD

Pediatric Keloid Disorder. Case Series of 30 patients from Tunisia

Emna Bahloul, MD

Psycho-Social Impact of Keloid Disorder

Lina Ndjok Mbolong

Keloids of the Feet

Song Kexin, MD

Clinical Case Presentation: Ear Keloid in a Patient with Albinism

Jonel May Breytenbach, MD

Clinical Case Presentation: Spontaneous Keloid Syndrome

Jfri Abdulhadi, MD

10:30-11:00

Coffee Break & Exhibition

11:00 – 12:30

Basic Science of Keloid Disorder

Gene Expression in Keloids and Pleiotropic Effects of Risk Factors for Fibroproliferative Disease

Shirley Brody Russell, PhD

Genetics of Keloid Disorder

Ernst Reichenberger, PhD

Progress in Keloid Animal Models

Dorothy Supp, PhD

From Experimental Data to a Numerical Model of “Keloid-Surrounding Skin” Somposite Structure

Gwenaël Rolin, PhD

Keloids: Proliferative or Inflammatory disorder?

Ferdinand Nangole, MD

Advancing the Study of Keloids with In-Vitro Modeling and Single-Cell Sequencing

Scott MacDonnell, PhD

Halofuginone vs TGF-Mediated Fibrosis: in Vitro Investigations on Site-Specific Keloid Fibroblasts

Gwenaël Rolin, PhD

12:30 – 13:30

Lunch Break & Exhibition

12:30 – 13:30

Special Session: Keloid Nomenclature Working Group: Aiming to Harmonize Definitions and to Adopt Standard Nomenclature. This Session is Open to all Participants.

13:30 – 15:00

Role of Surgery in Treatment of Keloid Lesions

Optimization of Surgical Management for the Treatment of Auricular Keloids

Tae Hwan Park, MD, PhD

Intralesional Surgery in Combination with Contact Cryotherapy

Frank Niessen, MD, PhD

A Dermatologic Surgeon’s Approach to Keloids

Jürg Hafner, MD

Role of Adjuvant Radiation Therapy in Management of Keloid Lesions

Jonathan Tsao, MD

Algorithm for Treatment of Chest Wall Keloids. Report of a large study from Peking Union Medical College Hospital

Xiao Long, MD

Subcutaneous Surgical Resection of Keloid Lesions

Wang Youbin, MD

Four Decades of Experience with Radiation Therapy in Treating Keloid Lesions at the Royal Marsden Hospital, London, St George’s University Hospital, London and Cancer Centre London. Current Procedures and Potential for Future Developments

John Glees, MD, FRCR, DMRT

 

Estimates of Radiation Risks Arising from the Treatment of Keloids by Radiotherapy.

Henry Weatherburn, PhD

15:00-15:30

Coffee break & exhibition

15:30: 17:30

Non-Surgical Management of Keloid Lesions

Intralesional Steroids – Efficacy and Side effects

Role of Lasers and Light-based Devices in Treatment of Keloids: When, Where and How?

Reza Ghohestani, MD, PhD

Role of Cryotherapy in Treatment of Bulky Keloids.

Michael H. Tirgan, MD

Abstract Presentation: 595nm Pulsed Dye Laser For Hypetrophic And Keloid Scars Treatment. A Randomized-Controlled Study

Angela Filoni, MD

Clinical Abstract Presentation: Painful Keloids. Evaluation of Risk Factors and Recommendation for Treatment.

Sofie De Schrijver, MD

Steroid tape as an adjunct in the management of keloid and hypertrophic scars.

Ioannis Goutos, FRCSEd (Plast)

Keloidal morphea : Report of an atypical case with satisfying outcome.

Emna Bahloul, MD

Clinical Case Presentation: Earlobe keloid regression by bottom ligature and injection with corticosteroid and 5-FU

Wang XiQiao, MD

17:30-19:00

Reception

20:00 – 23:00

Faculty Dinner

Time

Title

Speaker

DAY 2
Friday, June 8, 2018

7:30 – 8:30

Registration and Breakfast

8:30 -10:30

Clinical Research / Abstract Presentations

Optimization of surgical management for the treatment of auricular keloids

Tae Hwan Park, MD

The effects of post-operative intralesional corticosteroids in the prevention of recurrent earlobe keloids: A multispecialty retrospective review

Lamont Jones, MD, MBA

Hypo-fractionated Electron Beam Radiation Therapy, a Retrospective Analysis of 568 Keloid Patient with 834 Keloid Lesions

Xiao Long, MD

Research in Post Sternotomy Keloids

Frank Niessen, MD, PhD

Treating Keloids with Adjuvant High-Dose Rate Brachytherapy

Jonathan Tsao, MD

Brachytherapy as an adjunct in the management of keloid lesions

Ioannis Goutos, FRCSEd (Plast)

Auricular Keloid Management: Clinical Outcome of Intralesional Excision and Postoperative Triamcinolone Acetonide Intralesional Injection

Young-Jun Choi, MD

THE KELOIDS BANE, WITHOUT THE PAIN – A New Approach in the Treatment of Keloids: Tixel-Associated topical Triamcinolone acetonide and 5-fluorouracil delivery

Ofir Artzi, MD

10:30-11:00

Coffee Break & Exhibition

11:00 – 12:30

Basic Science Research / Abstract Presentation

The MicroRNA Methylome Landscape in Keloid Pathogenesis

Lamont Jones, MD, MBA

Can anomalies of the Atypical Chemokine Receptor 1 (ACKR1) gene explain the dysregulated microenvironment of keloids and some aggressive breast cancer subtypes?

Haythem Y. Ali, MD

Canvassing tissue microenvironments for immune disease markers as potential candidates of immunotherapy responsiveness: applicability to keloid pathogenesis”.

Maria Worsham, PhD

Admixture mapping and increased risk factors for fibrosis in African ancestry populations

Shirley Brody Russell, PhD

A comparison of apoptosis levels in keloid tissue, physiological scars and normal skin.

Xiao Long, MD

Micro/Nanotechnology for diagnosis and treatment of keloids and hypertrophic scars.

David Yeo, PhD

Role of Mechanosignaling pathways in Keloid Formation and Progression.

Hesham Moneer Ahmad, MD

12:30 – 13:30

Lunch Break & Exhibition

12:30 – 13:30

Special Session: Keloid Clinical Trial Working Group – Randomized Study of Surgery v. Cryotherapy in Patients with Ear Keloids. This Session is Open to all Participants.

Jürg Hafner, MD

13:30 – 15:00

Vision / Future of Keloid Research

Early inflammatory differences between normotrophic and hypertrophic scars in humans

Frank B. Niessen, MD, PhD

Embryonic Stem Cell-Like Population within KALTS in Keloid Scar Expresses Components of the Renin-angiotensin System and Cathepsins B, D and G.

Swee Tan, MBBS FRACS PhD

Evolution of management of Keloids -from what it was , what it is and the things to come in future.

Kamal Malaker, MD

Deactivating activin: a new direction in the treatment of keloids

Peter Temple-Smith, PhD

 

Changes to Fibroblast Phenotype in Keloid Disorder

 

Mark Fear, PhD

 

Shortcomings of Surgery in Treatment of Keloids / Debate / Clinical Case Presentations

Michael H Tirgan MD

15:00-15:30

Coffee break & exhibition

15:30: 17:00

Clinical Research Session / Abstract Presentation

Incidence of Hypertension among Keloid Patients

Joel Correa da Rosa, PhD

Efficacy of a Multimodal Approach for treatment of Keloids

Reza Ghohestani, MD PhD

Vitamin D Receptor Expression in Keloids

Dorothy Supp, PhD

Study of Hyperbaric Oxygen Treatment in Keloid Patients

Wang Youbin, MD

Multiscale analysis of a keloid by imaging and biomechanical devices

Gwenaël Rolin, PhD

Clinical Abstract Presentation: Use of pneumatic needle-free injection technology for treatment of keloid scars in adult patients

Daniel Cassuto, MD

Closing Remarks

17:30-19:00

Reception

20:00 – 23:00

Gala Dinner